Kawasaki Syndrome

views updated

Kawasaki Syndrome

Introduction

Disease History, Characteristics, and Transmission

Scope and Distribution

Treatment and Prevention

Impacts and Issues

BIBLIOGRAPHY

Introduction

Kawasaki syndrome is a disease of unknown cause that can affect children of any age, but tends to be most prevalent in children younger than five years of age. The disease causes acute symptoms including fever, rash, swelling, irritations in the eyes and around the mouth, and red or peeling hands and feet. In more serious cases, Kawasaki syndrome can lead to heart complications such as congestive heart failure, along with coronary artery dilations and aneurysms, both of which increase the risk of heart attacks. Kawasaki is the leading cause of acquired heart disease in children, with around 20% of children with Kawasaki syndrome developing aneurysms (thinned, weakened areas of arteries) within two weeks if the condition is not treated.

Kawasaki syndrome occurs worldwide, with a higher occurrence in Japan. It is treatable using an administration of aspirin, or via a treatment known as gamma globulin (a group of proteins in blood plasma that contains many antibodies). Due to the risk of heart complications being enhanced when treatment is delayed or not given, treatment is vital to prevent complications arising. As its causes are unknown, there is no known way to prevent contracting Kawasaki syndrome.

Disease History, Characteristics, and Transmission

Kawasaki syndrome was first described by Tomisaki Kawasaki in Japan in 1967. The disease mostly affects children and has become the most common cause of heart disease in children from developed countries. The cause of this disease is unknown although suggested causes include exposure to a toxin, exposure to chemicals used in carpet cleaning, and exposure to an airborne pathogen. The incidence of Kawasaki syndrome is also higher in Japan, and within the United States, the incidence is greatest in individuals of Asian and Pacific Island descent. This suggests that there may be a genetic component that predisposes individuals to the disease.

After acquiring Kawasaki syndrome, patients develop acute (rapid onset) symptoms. These include: fever; rash; swelling of the hands and feet; swollen lymph nodes; irritation and inflammation of the mouth, lips, and tongue; red eyes; and red palms of the hands and soles of the feet. Chronic symptoms include coronary artery dilatations and aneurysms, which leads to an increased chance of a heart attack.

Since the cause of the disease is unknown, little is known about the transmission of Kawasaki syndrome. However, it is known that the disease is not contagious.

Scope and Distribution

Kawasaki syndrome was first diagnosed in Japan, and the highest incidence of this disease remains in Japan. However, Kawasaki syndrome occurs worldwide. In the United States, around 4,000 children are diagnosed with the condition each year.

Children under the age of five years are at greatest risk of developing Kawasaki syndrome. In 2000, within the United States, 77% of all children being treated for Kawasaki syndrome were under five years of age, and peak prevalence occurred in children aged 18–24 months. However, older children, including teenagers, also develop the disease. Worldwide, cases of Kawasaki syndrome are uncommon before age six months, and this is thought to be due to the protective action of maternal antibodies.

Incidence of Kawasaki syndrome also appears to be influenced by sex and race. Males tend to be more prone to developing the disease, as are children of Asian or Pacific Island descent. Studies have also shown that Kawasaki syndrome in the United States is linked to socioeconomic status, with the disease more common in families with a high median household income.

Most incidences of Kawasaki syndrome occur during winter or early spring, suggesting that the disease may have a winter-spring seasonality.

WORDS TO KNOW

ANTIBODY: Antibodies, or Y-shaped immunoglobulins, are proteins found in the blood that help to fight against foreign substances called antigens. Antigens, which are usually proteins or polysaccharides, stimulate the immune system to produce antibodies. The antibodies inactivate the antigen and help to remove it from the body. While antigens can be the source of infections from pathogenic bacteria and viruses, organic molecules detrimental to the body from internal or environmental sources also act as antigens. Genetic engineering and the use of various mutational mechanisms allow the construction of a vast array of anti-bodies (each with a unique genetic sequence).

ACUTE: An acute infection is one of rapid onset and of short duration, which either resolves or becomes chronic.

AUTOIMMUNITY: Autoimmune diseases are conditions in which the immune system attacks the body's own cells, causing tissue destruction. Autoimmune diseases are classified as either general, in which the autoimmune reaction takes place simultaneously in a number of tissues, or organ specific, in which the autoimmune reaction targets a single organ. Autoimmunity is accepted as the cause of a wide range of disorders, and is suspected to be responsible for many more. Among the most common diseases attributed to autoimmune disorders are rheumatoid arthritis, systemic lupus erythematosis (lupus), multiple sclerosis, myasthenia gravis, pernicious anemia, and scleroderma.

GAMMA GLOBULIN: Gamma globulin is a term referring to a group of soluble proteins in the blood, most of which are antibodies that can mount a direct attack upon pathogens and can be used to treat various infections.

PREVALENCE: The actual number of cases of disease (or injury) that exist in a population.

Treatment and Prevention

People who have developed Kawasaki syndrome require hospitalization during which time they are treated with aspirin and an intravenous treatment known as gamma globulin (IVGG). IVGG treatment contains antibodies and comes from donor blood. This treatment is given for 8 to 12 hours and acts to decrease fever and to lower the risk of heart complications. Aspirin is also administered for both its anti-inflammatory action and to lower fever. In the majority of cases where treatment is given within 10 days after disease onset, recovery from acute symptoms is complete and heart problems are unlikely. However, the risk of developing heart problems increases the longer the patient goes without treatment.

Although recovery of the acute symptoms of Kawasaki syndrome is possible without treatment, the risk of heart problems is significant. Approximately 20–25% of children may develop enlargement of the heart and its arteries if left without treatment. This increases the likelihood of heart problems, and other complications such as arthritis, meningitis, and death. As the cause of this disease is unknown, there is no definitively known way to prevent contracting the disease.

Impacts and Issues

Kawasaki syndrome has become the leading cause of acquired heart problems in children less than five years of age who live in developed countries. Kawasaki syndrome now has this number one distinction after the incidence of scarlet fever (along with the rheumatic heart disease that often accompanied it) has dropped dramatically due to the introduction of antibiotics in the 1940s.

As there is no current prevention against contracting Kawasaki syndrome, it is important that patients be identified and treated as soon as possible. Furthermore, the risk of heart disease and other medical complications increases when treatment is not administered or when treatment is delayed. This is another reason why rapid administration of treatment is necessary.

Determining the cause of the disease would increase the likelihood of being able to control and prevent Kawasaki syndrome. Research has been conducted since the disease was first diagnosed in 1967. However, the specific cause for the disease remains unknown. In addition, it remains unknown whether the disease is caused by reaction to a chemical or toxin, or is a classic infectious disease of bacterial or viral origin. Current research points to an infectious trigger for the disease, but many scientists consider an autoimmune component (a condition where the body's immune system falsely interprets its own tissues as foreign and attacks them) to be an important factor in the development of the disease. Kawasaki syndrome presents researchers with the challenge of solving a mysterious link between infectious disease and autoimmunity.

See AlsoChildhood Infectious Diseases, Immunization Impacts; Demographics and Infectious Disease; Immune Response to Infection.

BIBLIOGRAPHY

Periodicals

Pemberton M.N., I.M. Doughty, R.J. Middlehurst, and M.H. Thornhill. “Recurrent Kawasaki Disease.” British Dental Journal. 186 (1999): 6, 270–271.

Web Sites

Centers for Disease Control and Prevention. “Kawasaki Syndrome.” Jan. 10, 2006 <http://www.cdc.gov/ncidod/diseases/kawasaki/index.htm> (accessed February 28, 2007).

Kawasaki Disease Foundation. “Kawasaki Disease Foundation: Caring for Precious Hearts.” <http://www.kdfoundation.org/> (accessed February 28, 2007).

Maryland Department of Health and Mental Hygiene. “Kawasaki Disease Fact Sheet.” May 2002 <http://edcp.org/factsheets/kawasaki.html> (accessed February 28, 2007).

More From encyclopedia.com